𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dendritic cell–tumor cell hybrids and immunotherapy: what's next?

✍ Scribed by Cathelin, Dominique; Nicolas, Alexandra; Bouchot, André; Fraszczak, Jennifer; Labbé, Jérôme; Bonnotte, Bernard

Book ID
122686085
Publisher
Informa plc
Year
2011
Tongue
English
Weight
369 KB
Volume
13
Category
Article
ISSN
1465-3249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy using allogeneic squamous
Immunotherapy using allogeneic squamous cell tumor–dendritic cell fusion hybrids
✍ Walter T. Lee; Chunrui Tan; Gary Koski; Suyu Shu; Peter Cohen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

## Abstract ## Background Tumor‐associated antigens (TAAs) are known to be immunotherapy targets; thus tumor‐sharing TAA may be used as a fusion hybrid partner to confer protection against subsequent tumor challenge. ## Methods The squamous cell carcinomas (SCCs), SCCVII and B4B8, were used in C

Dendritic cell immunotherapy
Dendritic cell immunotherapy
✍ Sabado, Rachel Lubong; Bhardwaj, Nina 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB